CSS
ORIC icon

Cubist Systematic Strategies’s Oric Pharmaceuticals ORIC Stock Holding History

Cubist Systematic Strategies’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,309
Closed -$36K – 4110
2023
Q1 		$36K Buy
6,309
+836
+15% +$4.37K ﹤0.01% 3610
2022
Q4 		$32.2K Sell
5,473
-8,090
-60% -$27.3K ﹤0.01% 3957
2022
Q3 		$43K Buy
13,563
+147
+1% +$588 ﹤0.01% 4150
2022
Q2 		$60K Sell
13,416
-62,183
-82% -$248K ﹤0.01% 4067
2022
Q1 		$404K Buy
+75,599
New +$681K ﹤0.01% 2663
2021
Q4 		– Sell
-2,145
Closed -$45K – 3581
2021
Q3 		$45K Sell
2,145
-8,879
-81% -$180K ﹤0.01% 2844
2021
Q2 		$195K Buy
11,024
+9,674
+717% +$212K ﹤0.01% 2574
2021
Q1 		$33K Buy
+1,350
New +$42.7K ﹤0.01% 2752
2020
Q3 		– Sell
-10,598
Closed -$357K – 2587
2020
Q2 		$357K Buy
+10,598
New +$338K 0.01% 1768

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return